niacinamide has been researched along with Psychotic Disorders in 11 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manka, JT | 1 |
Vinson, PN | 1 |
Gregory, KJ | 1 |
Zhou, Y | 1 |
Williams, R | 1 |
Gogi, K | 1 |
Days, E | 1 |
Jadhav, S | 1 |
Herman, EJ | 1 |
Lavreysen, H | 1 |
Mackie, C | 1 |
Bartolomé, JM | 1 |
Macdonald, GJ | 1 |
Steckler, T | 1 |
Daniels, JS | 1 |
Weaver, CD | 1 |
Niswender, CM | 1 |
Jones, CK | 1 |
Conn, PJ | 1 |
Lindsley, CW | 1 |
Stauffer, SR | 1 |
THIBAULT, H | 1 |
ROBERT, D | 1 |
NIKOLIC, V | 1 |
KAPAMADZIJA, B | 1 |
NIKOLIC, L | 1 |
MCDONALD, RL | 1 |
REGO NETO, F | 1 |
Pozzilli, P | 1 |
Andreani, D | 1 |
Guareschi-Cazzullo, A | 1 |
Bertolini, M | 1 |
Kuramitsu, M | 2 |
Okumura, Y | 1 |
Ikeda, M | 1 |
Ishii, N | 1 |
Kanig, K | 2 |
Oesterle, W | 1 |
Bartelheimer, HK | 1 |
Grüttner, R | 1 |
Simon, HA | 1 |
3 reviews available for niacinamide and Psychotic Disorders
Article | Year |
---|---|
The potential role of nicotinamide in the secondary prevention of IDDM.
Topics: Diabetes Mellitus, Type 1; Humans; Nervous System Diseases; Niacinamide; Psychotic Disorders; Skin D | 1993 |
Psychopharmacological perspectives in childhood psychoses.
Topics: Antidepressive Agents; Antipsychotic Agents; Brain Chemistry; Child; Depressive Disorder; Humans; Li | 1979 |
[Biochemical treatment possibilities in psychoses].
Topics: Amino Acids; Ascorbic Acid; Dihydroxyphenylalanine; Humans; Methionine; Niacinamide; Nicotinic Acids | 1969 |
8 other studies available for niacinamide and Psychotic Disorders
Article | Year |
---|---|
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossover.
Topics: Allosteric Regulation; Allosteric Site; Animals; Antipsychotic Agents; Ethers; Humans; Niacinamide; | 2012 |
[NEURO-PSYCHIATRIC COMPLICATIONS DUE TO ANTI-BACTERIAL DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cyclo | 1963 |
[A CASE OF ALCOHOLIC PSYCHOSIS IN A CHILD AGED 3 YEARS AND 4 MONTHS].
Topics: Child; Chlorpromazine; Humans; Niacin; Niacinamide; Psychoses, Alcoholic; Psychotic Disorders; Pyrid | 1963 |
IATROGENIC AMPHETAMINE PSYCHOSIS.
Topics: Amphetamine; Amphetamines; Electroconvulsive Therapy; Iatrogenic Disease; Niacinamide; Phenothiazine | 1964 |
[Nicotinamide and pellagrous psychoses].
Topics: Humans; Mental Disorders; Niacin; Niacinamide; Nicotinic Acids; Pellagra; Psychotic Disorders | 1951 |
[Alcoholic pellagra psychosis--six cases including an autopsied case].
Topics: Adult; Alcoholism; Brain; Diagnosis, Differential; Electroencephalography; Humans; Male; Middle Aged | 1991 |
[Biochemical mechanism of action of nicotinic acid, nicotinamide, methionine and D-penicillamine in treatment of psychoses].
Topics: Amines; Amino Acids; Biochemical Phenomena; Biochemistry; Humans; Methionine; Methylation; Niacinami | 1970 |
[Hartnup syndrome. I. Diagnosis, therapy and clinical course].
Topics: Adolescent; Cerebellar Ataxia; Diagnosis, Differential; Dietary Proteins; Electroencephalography; Ha | 1971 |